Drug Trial Radar · NCT07486934
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
May 14, 2026
Primary completion
Jul 2028
Study completion Jan 2029
Sponsor
- Lead sponsor
- Dyne TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment basivarsen (DYNE-101) for the treatment of myotonic dystrophy 1 (DM1).
Conditions
- Myotonic Dystrophy Type 1 (DM1)
- DM1
- Myotonic Dystrophy
- Steinert Disease
- Steinert
Interventions
zeleciment basivarsen (DYNE-101)Drug
Administered by IV infusion
PlaceboDrug
Administered by IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- 5 Times Sit-To-Stand (5×STS) TimeTime frame: Baseline, Week 49
Locations
45 sites in 12 countries. Site status is shown where the registry gives one.
UCSD - Altman Clinical and Translational Research Institute
La Jolla, California · Recruiting
UCLA Medical Center (Department of Neurology)
Los Angeles, California · Recruiting
Stanford Neuroscience Health Center
Palo Alto, California · Recruiting
UF Health: University of Florida Clinical Research Center
Gainesville, Florida · Recruiting
Rare Disease Research, LLC
Atlanta, Georgia · Recruiting
IU Health Neuroscience Center
Indianapolis, Indiana · Recruiting
Kennedy Krieger Institute
Baltimore, Maryland · Recruiting
Roy Blunt NextGen Precision Health Institute
Columbia, Missouri · Recruiting
University of Rochester Medical Center
Rochester, New York · Recruiting
Rare Disease Research, LLC
Hillsborough, North Carolina · Recruiting
Houston Methodist Neurological Institute
Houston, Texas · Recruiting
The University of Texas Health Science Center at San Antonio
San Antonio, Texas · Recruiting
University of Utah Clinical Neurosciences Center
Salt Lake City, Utah · Recruiting
Virginia Commonwealth University - Biotech One
Richmond, Virginia · Recruiting
St Vincent's Hospital, Melbourne
Fitzroy, Victoria, Australia · Recruiting
UZA
Edegem, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
Aarhus University Hospital, Department of Neurology
Aarhus, Denmark · Recruiting
Rigshospitalet, (Neuromuscular Clinic and Research Unit, Department 8077)
Copenhagen, Denmark · Recruiting
AP-HP, Hôpital Raymond-Poincaré
Garches, France · Recruiting
CHU Marseille - Hôpital de la Timone (APHM)
Marseille, France · Recruiting
CHU de Nantes - Hôtel-Dieu
Nantes, France · Recruiting
Pitié-Salpêtrière Hospital
Paris, France · Recruiting
CHU de Toulouse - Hôpital Pierre-Paul Riquet
Toulouse, France · Recruiting
LMU Klinikum der Universität München Neurologische Klinik und Poliklinik Friedrich-Baur-Institut Campus Innenstadt
Munich, Bavaria, Germany · Recruiting
Universitätsmedizin Göttingen
Göttingen, Lower Saxony, Germany · Recruiting
Universitätsklinikum Bonn AöR Zentrum für Neurologie Klinik für Neuroimmunologie und Neuromuskuläre Erkrankungen
Bonn, North Rhine-Westphalia, Germany · Recruiting
Charité Universitätsmedizin Berlin Campus-Buch Muscle Research Unit
Berlin, State of Berlin, Germany · Recruiting
Centro Clinico Nemo Brescia, Fondazione Serena ETS
Gussago, Brescia, Italy · Recruiting
Centro Clinico Nemo Milano, Fondazione Serena ETS
Milan, Milano, Italy · Recruiting
Fondazione Policlinico Universitario A. Gemelli IRCCS - Department of Women's, Child and Public Health Sciences - UOC Neuropsichiatria Infantile
Roma, Roma, Italy · Recruiting
Azienda Ospedaliero-Universitaria Sant'Andrea - UOC Neurologia
Roma, Roma, Italy · Recruiting
Niigata National Hospital, National Hospital Organization
Kashiwazaki, Niigata, Japan · Recruiting
The University of Osaka Hospital
Suita-shi, Osaka, Japan · Recruiting
National Hospital Organization Osaka Toneyama Medical Center
Toyonaka-Shi, Osaka, Japan · Recruiting
National Center Hospital, National Center of Neurology and Psychiatry (NCNP)
Kodaira, Tokyo, Japan · Recruiting
Yamaguchi University Hospital
Ube-Shi, Yamaguchi, Japan · Recruiting
University of Maastricht
Maastricht, Netherlands · Recruiting
Radboud University Medical Center
Nijmegen, Netherlands · Recruiting
University of Auckland
Auckland, Auckland, New Zealand · Recruiting
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.